Find Lawyers Today, Get Legal Help.
Home >> Legal News >> RECALLS AND SAFETY ALERTS SERIOUS FUNGAL INFECTIONS WITH SIMPONI
FDA News
BACK TO LAWYER CENTRAL LEGAL NEWS CENTER
RECALLS AND SAFETY ALERTS SERIOUS FUNGAL INFECTIONS WITH SIMPONI
August 10, 2009
FDA is reminding healthcare professionals about the risk of serious fungal infections with TNF blockers, including Simponi (golimumab), which was recently approved. TNF blockers are immunosuppressants used to treat chronic inflammatory diseases, incl...Related FDA Stories:
- Recalls and Safety Alerts Fire Hazard with Stabilet Infant Warmers..
- Recalls and Safety Alerts Heart Rhythm Problems with Haloperidol..
- Recalls and Safety Alerts Practicing Hospital Bed Safety..
Additional Legal Resources:
Complete the Form Below and Talk to Experienced Lawyers
